Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action
- PMID: 29929578
- DOI: 10.1016/j.biopsych.2018.05.004
Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action
Comment on
-
Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response.Biol Psychiatry. 2018 Jul 1;84(1):46-54. doi: 10.1016/j.biopsych.2018.01.008. Epub 2018 Jan 31. Biol Psychiatry. 2018. PMID: 29523415 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
